| Product Code: ETC7139578 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Estonia continued to see a steady flow of peptide drug conjugates import shipments, primarily sourced from top exporters like Germany, Lithuania, Italy, Slovenia, and Belgium. The market displayed low concentration levels with a Herfindahl-Hirschman Index (HHI) that remained notably low. The compound annual growth rate (CAGR) for the period 2020-2024 stood at a healthy 8.49%, showing sustained growth momentum. Furthermore, the growth rate for 2023-2024 accelerated to 9.4%, indicating a positive trend in the import market for peptide drug conjugates in Estonia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Estonia Peptide Drug Conjugates Market Overview |
3.1 Estonia Country Macro Economic Indicators |
3.2 Estonia Peptide Drug Conjugates Market Revenues & Volume, 2021 & 2031F |
3.3 Estonia Peptide Drug Conjugates Market - Industry Life Cycle |
3.4 Estonia Peptide Drug Conjugates Market - Porter's Five Forces |
3.5 Estonia Peptide Drug Conjugates Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Estonia Peptide Drug Conjugates Market Revenues & Volume Share, By Type, 2021 & 2031F |
4 Estonia Peptide Drug Conjugates Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Estonia Peptide Drug Conjugates Market Trends |
6 Estonia Peptide Drug Conjugates Market, By Types |
6.1 Estonia Peptide Drug Conjugates Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Estonia Peptide Drug Conjugates Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Estonia Peptide Drug Conjugates Market Revenues & Volume, By OctreoScan, 2021- 2031F |
6.1.4 Estonia Peptide Drug Conjugates Market Revenues & Volume, By Lutathera, 2021- 2031F |
6.1.5 Estonia Peptide Drug Conjugates Market Revenues & Volume, By Pepaxto, 2021- 2031F |
6.1.6 Estonia Peptide Drug Conjugates Market Revenues & Volume, By ANG1005, 2021- 2031F |
6.1.7 Estonia Peptide Drug Conjugates Market Revenues & Volume, By BT1718, 2021- 2031F |
6.2 Estonia Peptide Drug Conjugates Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Estonia Peptide Drug Conjugates Market Revenues & Volume, By Therapeutic, 2021- 2031F |
6.2.3 Estonia Peptide Drug Conjugates Market Revenues & Volume, By Diagnostic, 2021- 2031F |
7 Estonia Peptide Drug Conjugates Market Import-Export Trade Statistics |
7.1 Estonia Peptide Drug Conjugates Market Export to Major Countries |
7.2 Estonia Peptide Drug Conjugates Market Imports from Major Countries |
8 Estonia Peptide Drug Conjugates Market Key Performance Indicators |
9 Estonia Peptide Drug Conjugates Market - Opportunity Assessment |
9.1 Estonia Peptide Drug Conjugates Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Estonia Peptide Drug Conjugates Market Opportunity Assessment, By Type, 2021 & 2031F |
10 Estonia Peptide Drug Conjugates Market - Competitive Landscape |
10.1 Estonia Peptide Drug Conjugates Market Revenue Share, By Companies, 2024 |
10.2 Estonia Peptide Drug Conjugates Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |